Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-80,000
Closed -$9.07M 55
2024
Q2
$9.07M Buy
+80,000
New +$10.1M 0.67% 36
2023
Q4
Sell
-300,000
Closed -$28M 71
2023
Q3
$28M Buy
+300,000
New +$33.8M 2.26% 11
2023
Q2
Sell
-100,000
Closed -$11.6M 66
2023
Q1
$11.6M Buy
+100,000
New +$11.2M 1.23% 23
2019
Q4
Sell
-200,000
Closed -$7.46M 60
2019
Q3
$7.46M Buy
+200,000
New +$7.77M 0.58% 32

Other funds holding DXCM

WS Management's DXCM Position: Q2 2025 in Review

WS Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 1,949 shares — an estimated $133K sold.

WS Management first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $24.4M in Q3 2023. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • WS Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • WS Management sold 1,949 DexCom shares in Q2 2025, an estimated $133K.
  • WS Management first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
  • WS Management's DexCom position peaked at $24.4M in Q3 2023.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on WS Management's 13F filing for Q2 2025, filed 14 Aug 2025.